A large multicenter clinical trial co-led by University of Maryland School of Medicine researchers found that an antiseptic containing iodine resulted in about one-quarter fewer post-surgical infections in patients with limb fractures compared to another frequently used skin antiseptic.
Researchers in the Department of Radiation Oncology at the University of Maryland School of Medicine (UMSOM) presented significant findings in two studies featured today at the American Society for Radiation Oncology (ASTRO) annual meeting in San Diego.
University of Maryland School of Medicine (UMSOM) Dean Mark T. Gladwin, MD, and University of Maryland Medical Center (UMMC) President and CEO Bert W. O’Malley, MD, announced today that Taofeek K. Owonikoko, MD, PhD, a distinguished physician-scientist with a global reputation in thoracic oncology, has been appointed Executive Director of the University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center (UMGCCC).
University of Maryland Medical Center, located in the healthcare hub city of Baltimore, receives national recognition for its academic maternal care units.
The R Adams Cowley Shock Trauma Center at the University of Maryland Medical Center (UMMC) hosted its 32nd annual Shock Trauma Heroes Celebration Saturday, honoring more than 40 trauma professionals and first responders who worked together to save the life of a 51-year-old highway construction worker whose legs were crushed when he was struck by a car on I-95 and pinned against his truck. He nearly bled to death from his injuries.
University of Maryland Children's Hospital Continues to Add or Enhance Existing Services for Children and their Families in Psychiatric Crisis.
The University of Maryland Children's Hospital is named a “Best Children’s Hospital” for Pediatric Cardiology & Heart Surgery by U.S. News & World, which also lauded UMCH as the #2 children’s hospital in Maryland and one of the top 15 in the Mid-Atlantic region.
The University of Maryland Medical Center celebrates the groundbreaking of a nine-story patient care tower – the Roslyn and Leonard Stoler Center for Advanced Medicine – that will become the new home of the University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center. The $219 million building will enable the cancer center to provide the most technologically advanced, integrated care to cancer patients throughout Maryland and the region well into the future
University of Maryland Medicine has officially eliminated race as a factor in birthing decisions, replacing a calculator which led doctors to recommend a surgical Cesarean section to Black or Hispanic women who had a previous C-section, compared to women of other races or ethnicities.
Weight loss for adults, particularly those who are overweight or obese, may reduce their risk of developing a type of polyp that can lead to colorectal cancer, according to a new study led by researchers at the University of Maryland School of Medicine. Findings were published today in the journal JNCI Cancer Spectrum. Losing weight from early to late adulthood (up to the mid-70s) – at least two pounds per decade – reduced an individual’s risk for developing precancerous growths, or adenomas, by 46 percent, the investigators reported. Study findings particularly support a benefit of weight loss for adults who are overweight or obese.
An ongoing study just published in The New England Journal of Medicine was pivotal in allowing mixed use of booster COVID-19 shots -- critical as the U.S. experienced the Omicron surge.
University of Maryland Medicine will end use of a long-standing clinical standard that factors a patient’s race into the diagnosis of chronic kidney disease. The change could increase access to specialty care including transplant for thousands of Black people living with advanced kidney disease.
.UMMC Stroke Care Center earns Gold Plus designation and other honors from American Heart Association rapid response and high adherence to stroke care guidelines.
Researchers at the University of Maryland School of Medicine (UMSOM) launched a new online tool that could more quickly advance medical discoveries to reverse progressive hearing loss. The tool enables easy access to genetic and other molecular data from hundreds of technical research studies involving hearing function and the ear.
The University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center (UMGCCC) has earned renewal of its National Cancer Institute (NCI) designation as a Comprehensive Cancer Center for another five years. The prestigious distinction recognizes the cancer center’s high caliber of scientific leadership and robust programs in basic, clinical and population science research, placing it in the top echelon of cancer centers nationwide.
.s the COVID-19 pandemic wanes in the U.S., a new study from the University of Maryland School of Medicine (UMSOM) and University of Maryland Medical Center (UMMC) finds that hospitals nationwide may not be adequately prepared for the next pandemic.
Researchers at the University of Maryland School of Medicine (UMSOM) have received a $5 million federal grant to pool genomic information from existing and new datasets – predominantly in African and African American populations -- in order to calculate the risk of developing specific diseases. They will use sophisticated modeling and genetic datasets to calculate the risk, known as a polygenic risk score, with an emphasis on studying people from different ancestries.
Researchers Develop More Reliable Rapid Tests for COVID-19 Public Release Date: 15-Jun-2021 00:00:00 US Eastern Time (24hr) Research News Release Contact Person: Deborah Kotz Contact Phone: 410-706-4255 Contact E-mail: [email protected] Journal: Nature Protocols DOI: 10.1038/s41596-021-00546-w Funder: Grant Number(s): Meeting: Primary Keyword: Medicine/Health Keywords: Medicine/Health -> Diagnostics Medicine/Health -> Infectious/Emerging Diseases Subtitle: Tests Use Innovative Techniques That Improve Accuracy Rivaling Gold Standard PCR Test Summary: Researchers at the University of Maryland School of Medicine (UMSOM) have developed two rapid diagnostic tests for COVID-19 that are nearly as accurate as the gold-standard test currently used in laboratories. Unlike the gold standard test, which extracts RNA and uses it to amplify the DNA of the virus, these new tests can detect the presence of the virus in as little as five minutes using different methods.
Public health measures designed to reduce the spread of the COVID-19 virus may have fostered a substantial side benefit: A 53 percent drop in hospital admissions for chronic obstructive pulmonary disease (COPD), likely due to a drop in circulating seasonal respiratory viruses such as influenza.
.Researchers from the University of Maryland School of Medicine (UMSOM) and their colleagues found that nearly 20 percent of patients with unexplained sudden cardiac death – most of whom were under age 50 – carried rare genetic variants. These variants likely raised their risk of sudden cardiac death.
Each city has its own unique microbiome, a "fingerprint" of viruses and bacteria that uniquely identify it, according to a new study from an international consortium of researchers that included a team from the University of Maryland School of Medicine (UMSOM). The international project, which sequenced and analyzed samples collected from public transit systems and hospitals in 60 cities around the world, was published today in the journal Cell.
Pregnant women who develop severe COVID-19 infections that require hospitalization for pneumonia and other complications may not be more likely to die from these infections than non-pregnant women. In fact, they may have significantly lower death rates than their non-pregnant counterparts.
Researchers at the University of Maryland School of Medicine began enrolling children ages 6 months to 11 years old in a clinical trial of the Moderna mRNA-1273 COVID-19 vaccine, which has already received Food and Drug Administration Emergency Use Authorization for adults.
Primary care practitioners often over-estimate the likelihood of a patient having a medical condition based on reported symptoms and laboratory test results. Such overestimations can lead to over-diagnosis and overtreatment, according to a recent study conducted by researchers at the University of Maryland School of Medicine (UMSOM) published in JAMA Internal Medicine.
Jacques Ravel, PhD In an effort to monitor the spread of COVID-19 variants in the State of Maryland, University of Maryland School of Medicine (UMSOM) Dean E. Albert Reece, MD, PhD, MBA, announced that UMaryland Genomics at UMSOM will perform genome sequencing of variants in at least 10 percent of COVID-19 test samples, reaching an important benchmark set by the federal government to help control the spread of these variants.
More than 65 first responders and top trauma medicine professionals who saved the lives of two critically ill patients were honored tonight at the 31st annual R Adams Cowley Shock Trauma Celebration of Heroes. Funds raised by the virtual event will support the Center for Critical Care and Trauma Education.
While it has already been established that those with Type II diabetes and a high body mass index (BMI) are at greater risk of experiencing hospitalizations and other severe complications related to COVID-19, they are also at greater risk of getting symptomatic infection in the first place.
Researchers at the University of Maryland School of Medicine (UMSOM) have been awarded $100,000 in funding through the Eugene Washington PCORI Engagement Awards, an initiative of the Patient-Centered Outcomes Research Institute (PCORI). The funds will support a national discussion and conference aimed at identifying evidence gaps to guide future research on the use of active surveillance to monitor low-risk prostate cancers. This serves as an alternative to immediate treatment with surgery, radiation or hormone therapy which all have potential debilitating side effects.
University of Maryland School of Medicine (UMSOM) researchers have identified the most toxic proteins made by SARS-COV-2—the virus that causes COVID-19 – and then used an FDA-approved cancer drug to blunt the viral protein’s detrimental effects.
University of Maryland School of Medicine (UMSOM) Dean E. Albert Reece, MD, PhD, MBA, a widely recognized visionary leader who elevated the UMSOM into a top-tier biomedical research and patient-focused academic center, announced that he will complete his 16-year tenure as Dean, at the end of the next academic year.
University of Maryland School of Medicine (UMSOM) Dean E. Albert Reece, MD, PhD, MBA, announced today that Jill RachBeisel, MD, Associate Professor of Psychiatry, has been appointed to serve as the Chair of the Department of Psychiatry, effective immediately. Dr. RachBeisel has served as the Department’s Interim Chair for the past two years and was previously Acting Chair and Vice Chair of the Department.
University of Maryland School of Medicine (UMSOM) Dean E. Albert Reece, MD, PhD, MBA, along with UMSOM Board of Visitors Chair Cynthia Egan, announced today that Michael Greenebaum, a prominent business leader and philanthropist who has served on the UMSOM’s Board since 2012, has been named Vice Chair of the Board of Visitors.
Dr. Kathleen Neuzil, MD, MPH, FIDSA, the Myron M. Levine, MD, DTPH, Professor in Vaccinology and Director of the University of Maryland School of Medicine’s (UMSOM)’s Center for Vaccine Development and Global Health (CVD), has been named this year’s “Marylander of the Year” by the Baltimore Sun.
Preschoolers living in impoverished communities who have access to a nurturing home environment have significantly higher intelligence quotient (IQ) scores in adolescence compared to those raised without nurturing care.
Hospitalized COVID-19 patients have a greater risk of dying if they are men or are obese or have complications from diabetes or hypertension, according to a new study conducted by University of Maryland School of Medicine (UMSOM) researchers. In a study published in the journal Clinical Infectious Diseases, the researchers evaluated nearly 67,000 hospitalized COVID-19 patients in 613 hospitals across the country to determine link between common patient characteristics and the risk of dying from COVID-19.
Researchers at the University of Maryland School of Medicine published one of the most comprehensive analyses of how genes get expressed during infection (known as a transcriptome). The analyses include three different strains of the bacteria Streptococcus pneumoniae, which causes pneumonia, meningitis and middle-ear infections.
Researchers at the University of Maryland School of Medicine (UMSOM) have discovered new drug compounds to potentially treat the novel coronavirus that causes COVID-19. This finding could lead to the development of new broad-spectrum antiviral drugs that target viruses such as influenza, Ebola and coronaviruses.
Hospitalized COVID-19 patients who were taking a daily low-dose aspirin to protect against cardiovascular disease had a significantly lower risk of complications and death compared to those who were not taking aspirin, according to a new study led by researchers at the University of Maryland School of Medicine (UMSOM).
Use of preventive antimalarial treatments reduces by half the number of malaria infections among schoolchildren, according to a new analysis published today in The Lancet Global Health.
New research finds wide variations in the way hospitals ensure that premature or low birth weight infants can breathe safely in a car seat before they're discharged. The same infant who passes a screening in one hospital’s newborn nursery may fail in similar facilities at another hospital’s nursery.
Researchers at the University of Maryland School of Medicine (UMSOM) have developed a novel technology to test for the presence of thin membrane protrusions called “microtentacles” on breast cancer cells, which can help predict whether a tumor is likely to spread. They describe the TetherChip device in a new paper published today in the Royal Society of Chemistry journal Lab on a Chip.
Researchers at the University of Maryland School of Medicine (UMSOM) have for the first time identified stem cells in the region of the optic nerve, which transmits signals from the eye to the brain. The finding presents a new theory on why the most common form of glaucoma may develop and potential for new therapies.
University of Maryland School of Medicine (UMSOM) Dean, E. Albert Reece, MD, PhD, MBA, and Christine Lau, MD, MBA, The Dr. Robert W. Buxton Chair of Surgery at UMSOM, announced today the hiring of two internationally-renown transplant professionals: a surgeon scientist and a transplant scientist. The unique pair of transplant professionals provides UMSOM with a powerful combination of leadership in both clinical surgery and surgical science.
Researchers at the University of Maryland School of Medicine (UMSOM) evaluated several human antibodies to determine the most potent combination to be mixed in a cocktail and used as a promising anti-viral therapy against the virus that causes COVID-19.
The Institute of Human Virology (IHV) at the University of Maryland School of Medicine, a Global Virus Network (GVN) Center of Excellence, in collaboration with scientists from Campus Biomedico in Rome and Ulisse Biomed and University of Trieste, in Trieste, Italy announced today the results of studies showing an inverse correlation between average high daily temperatures and COVID-19 related death rates in different geographical areas.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right
